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a b s t r a c t
Previous studies in our laboratory discovered that SIX1 mRNA expression increased during in vitro
progression of HPV16-immortalized human keratinocytes (HKc/HPV16) toward a differentiation-
resistant (HKc/DR) phenotype. In this study, we explored the role of Six1 at early stages of HPV16-
mediated transformation by overexpressing Six1 in HKc/HPV16. We found that Six1 overexpression in
HKc/HPV16 increased cell proliferation and promoted cell migration and invasion by inducing epithelial–
mesenchymal transition (EMT). Moreover, the overexpression of Six1 in HKc/HPV16 resulted in
resistance to serum and calcium-induced differentiation, which is the hallmark of the HKc/DR
phenotype. Activation of MAPK in HKc/HPV16 overexpressing Six1 is linked to resistance to calcium-
induced differentiation. In conclusion, this study determined that Six1 overexpression resulted in
differentiation resistance and promoted EMT at early stages of HPV16-mediated transformation of
human keratinocytes.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Although screening is very effective in preventing cervical
cancer, approximately 500,000 new cases of cervical cancer are
diagnosed and 280,000 deaths result from this disease annually
(Peralta-Zaragoza et al., 2012). The etiological agent for cervical
cancer is an infection with a high risk human papillomavirus
(HPV). HPV16 accounts for 55–60% of all cervical cancer while
HPV18 accounts for another 10–15% of cervical cancers (de Sanjose
et al., 2010; Munoz et al., 2003; Walboomers et al., 1999). While
most HPV infections are asymptomatic and are cleared naturally,
in some individuals the HPV infection remains persistent, which
can then lead to cervical intraepithelial neoplasia (CIN) and over
time cervical cancer (Saslow et al., 2012).
To explore the cellular and molecular events associated with
HPV16-mediated transformation and progression, we have estab-
lished an in vitro model, which in many respects mimics the distinct
stages of premalignant progression. In this model normal human
foreskin keratinocytes (HKc) are immortalized by transfection with a
plasmid containing a head-to-tail dimer of HPV16 DNA (HKc/HPV16).
HKc/HPV16 are cultured in serum-free medium supplemented with
epidermal growth factor (EGF) and bovine pituitary extract (BPE)
(Pirisi et al., 1987). Growth factor-independent HKc (HKc/GFI) are
then selected by culturing HKc/HPV16 in medium lacking EGF and
BPE. Finally, differentiation resistant cells (HKc/DR) are selected from
HKc/GFI in medium containing 1 mM calcium chloride and 5% fetal
bovine serum (FBS) (Pirisi et al., 1988). By comparing the gene
expression proﬁles of HKc/DR and HKc/HPV16, we identiﬁed Six1
as a gene whose expression is signiﬁcantly increased in HKc/DR
(Wan et al., 2008).
Six1 is a member of the Six family of homeodomain trans-
cription factors and is a key regulator essential for the proper
development of numerous organs (Ikeda et al., 2010; Xu et al., 2003;
Zheng et al., 2003). Six1 overexpression has been found in various
human cancers. (Behbakht et al., 2007; Coletta et al., 2008; Ng et al.,
2010; Zheng et al., 2010). The overexpression of Six1 is usually
associated with increased tumor progression and metastasis, and
decreased survival (Christensen et al., 2008). For example, Six1
overexpression in cervical cancer cell lines and cervical cancer
tissues is correlated with increased malignancy and lymph node
metastasis (Tan et al., 2011; Zheng et al., 2010). While our initial
work determined that the expression of SIX1 mRNA increased in
HKc/DR compared to HKc/HPV16 (Wan et al., 2008), we more
recently reported that overexpression of Six1 in HKc/DR increased
cell motility, induced epithelial–mesenchymal transition (EMT), and
resulted in malignant conversion (Xu et al., 2014). Furthermore,
induction of EMT by Six1 overexpression in HKc/DR was associated
with activation of transforming growth factor beta receptor type 2
(TβRII)-p38 signaling (Xu et al., 2014). The fact that Six1 expression
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increased during in vitro progression of HPV16-immortalized cells
and Six1 was overexpressed in cervical cancer tissues (Wan et al.,
2008; Zheng et al., 2010), strongly suggested that Six1 might also be
involved in premalignant progression. Therefore, in this study, we
explored the role of Six1 during the early stages of HPV16-mediated
transformation by overexpressing Six1 in HKc/HPV16. We found
that Six1 overexpression in HKc/HPV16 increased cell prolifer-
ation and induced cell migration and invasion by promoting EMT.
Importantly, the overexpression of Six1 in HKc/HPV16 resulted in
resistance to serum and calcium-induced differentiation. Finally, we
found that activation of MAPK signaling is linked to resistance to
calcium-induced differentiation in HKc/HPV16 overexpressing Six1.
Overall our results support the conclusion that Six1 overexpression
promotes differentiation resistance and EMT at early stages of
HPV16-mediated transformation of HKc.
Results
The expression of Six1 increases during HPV16-mediated
transformation of HKc
Previous studies in our laboratory discovered that the expres-
sion of SIX1 mRNA increased during in vitro progression of HKc/
HPV16 toward the HKc/DR phenotype (Wan et al., 2008). To
further explore overexpression of Six1 during in vitro progression
of HPV16-immortalized HKc, we conducted both RT-PCR and
Western blot analysis for Six1 in three independent sets of HKc/
HPV16 and HKc/DR lines (designated D1, D4 and D5), derived from
normal HKc isolated from three different foreskin donors. The
results showed that the expression of Six1 mRNA increased 200 to
over 600-fold in HKc/DR compared to their respective HKc/HPV16
lines (Fig. 1A) while protein levels of Six1 increased about 2-fold
(Fig. 1B). The biological basis for the much greater increase in Six1
mRNA levels relative to Six1 protein levels is unknown and
currently under study. Furthermore, the two bands of Six1 we
observed in the Western blots is consistent with published studies
and likely the result of posttranslational phosphorylation (Ford
et al., 2000; Micalizzi et al., 2010).
Six1 increases proliferation, migration and invasion in HKc/HPV16
To further explore the function of Six1 in HKc/HPV16, we cloned a
full-length human Six1 cDNA into the expression plasmid pcDNA3.1
(pcDNA3.1-Six1). HKc/HPV16-Six1 were established by stable trans-
fection of HKc/HPV16 with pcDNA3.1-Six1. HKc/HPV16-Ctrl were
HKc/HPV16 transfected with the pcDNA3.1 expression plasmid alone.
Western blots conﬁrmed the overexpression of Six1 in HKc/HPV16-
Six1 (Fig. 2A). HKc/HPV16-Six1 exhibited an elongated and more
ﬁbroblastic-like appearance rather than the typical cuboidal mor-
phology of HKc/HPV16-Ctrl (Fig. 2B). HKc/HPV16-Six1 also showed
increased cell proliferation compared to HKc/HPV16-Ctrl (Fig. 2C).
Moreover, Six1 overexpression in HKc/HPV16 increased cell invasion
by 4.5-fold and cell migration approximately 4.2-fold (Fig. 2D). These
data demonstrate that HKc/HPV16 overexpressing Six1 exhibited a
more mesenchymal phenotype with increased cell growth, migration
and invasion compared to HKc/HPV16-Ctrl.
Six1 promotes EMT
Due to the changes in cell morphology, growth and invasion
associated with Six1 overexpression, we next explored the expres-
sion of EMT related genes upon Six1 overexpression in HKc/HPV16.
As shown in Fig. 3A, the overexpression of Six1 resulted in increased
expression of mesenchymal markers and decreased expression of
epithelial markers. For example, the mRNA level of E-cadherin and
occludin decreased by about 81% and 76%, while mRNA levels of
vimentin and snail increased by 2.0-, and 4.3-fold respectively in
HKc/HPV16-Six1 when compared with HKc/HPV16-Ctrl (Fig. 3A).
Moreover, we examined the protein levels of E-cadherin and
ﬁbronectin by western blot analysis and immunoﬂuorescence. The
overexpression of Six1 in HKc/HPV16 led to decreased protein levels
of E-cadherin and slightly increased levels of ﬁbronectin (Fig. 3B
and C). We also investigated β-catenin, a key component of adherens
junctions in epithelial cells (Gumbiner, 2005), and found that protein
levels of β-catenin decreased dramatically in Six1-overexpressing
HKc/HPV16 (Fig. 3B). Taken together, our data show that Six1
overexpression promotes EMT in HKc/HPV16.
The overexpression of Six1 in HKc/HPV16 results in resistance to
serum and calcium-induced differentiation
We used Western blots to determined protein levels of Six1 at all
stages of our in vitro model for HPV16-mediated transformation. By
far, the most dramatic increase in Six1 expression was observed in
the ﬁnal HKc/DR stage compared to the earlier HKc/HPV16 and HKc/
GFI stages (supplemental Fig. 1). Normal HKc and HKc/HPV16 can be
Fig. 1. The expression of Six1 increases during in vitro progression of HPV16-immortalized human keratinocytes. (A) Real-time PCR analysis of Six1 mRNA in three
independently derived HKc/HPV16 (HKc) lines (D1, D4 and D5) and their corresponding HKc/DR (DR) lines. Six1 expression was normalized to β-actin. (B) Top: western blot
for Six1 in HKc/HPV16-D1, -D4 and -D5, (labeled as HKc) and their corresponding HKc/DR (labeled as DR). β-actin was used as control for equal protein loading. Bottom: the
expression of Six1 protein was quantiﬁed by ImageJ. Bars indicate standard deviation (SD) and nnn indicate statistically signiﬁcant p value o0.001.
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propagated in serum-free media and under low Ca2þ conditions
(30 mM), and media containing high-calcium (1 mM) or serum (5%)
triggers terminal squamous differentiation (Boyce and Ham, 1983;
Pirisi et al., 1988, 1987). The hallmark of HKc/DR is resistance to
serum and calcium-induced differentiation (Pirisi et al., 1988). There-
fore, we explored if the overexpression of Six1 is associated with
differentiation resistance. As shown in Fig. 4A, HKc/HPV16-Ctrl
stratiﬁed and expressed keratin 10, a differentiation marker, after
being treated with 1 mM Ca2þ or 5% FBS for 5 days. In contrast, HKc/
HPV16-Six1 did not stratify or express keratin 10 in response to
1 mM Ca2þ or 5% FBS treatment (Fig. 4A). We consistently found that
keratin 10 protein levels dramatically increased at day 5 following
1 mM calcium chloride treatment in HKc/HPV16-Ctrl, but not in HKc/
HPV16-Six1 (Fig. 5A). The change in cell morphology in HKc/HPV16-
Ctrl could be observed as early as 24 h post 1 mM Ca2þ or 5% FBS
treatment (Fig. 4B). HKc/HPV16-Six1 cultured in medium supple-
mented with 1 mM calcium chloride or 5% FBS showed a mixed
morphology of spindle-like cells as well as enlarged cobblestone
shaped cells, which is typical of the morphology exhibited by HKc/DR
(Fig. 4A, B).
The E-cadherin-β-catenin complex at the plasma membrane
plays a critical role in differentiation of normal HKc, and knocking-
down E-cadherin or β-catenin expression blocks calcium-induced
keratinocyte differentiation (Xie and Bikle, 2007). We thus examined
E-cadherin by immunoﬂuorescence and we found that both HKc/
HPV16-Six1 and HKc/HPV16-Ctrl exhibited increased membrane-
associated E-cadherin and intercellular junction formation when
exposed in high Ca2þ medium (Fig. 4A). We also used western
blotting to detect protein levels of total E-cadherin, ﬁbronectin, as
well as soluble (cytoplasmic) and insoluble (cytoskeletal-associated)
E-cadherin in HKc/HPV16-Ctrl and HKc/HPV16-Six1 after being
exposed to media containing 1 mM Ca2þ for varying times (10 min
to 5 days). We found that total E-cadherin remained relatively
unchanged and that the expression of ﬁbronectin decreased in both
HKc/HPV16-Ctrl and Six1-overexpressing cells upon high calcium
treatment (Fig. 5A). Consistent with what we observed by immuno-
ﬂuorescence, HKc/HPV16-Six1 exhibited increased insoluble
E-cadherin from 48 h after high calcium treatment, indicating the
formation of intercellular junctions (Fig. 5B). Phosphatidylinositol
3-kinase (PI3K)/AKT signaling can be activated by the E-cadherin
Fig. 2. Six1 overexpression in HKc/HPV16 changes cell morphology and increases cell proliferation, invasion and migration. (A) HKc/HPV16 were stably transfected with
either pcDNA3.1 (Ctrl) or pcDNA3.1-Six1 (Six1). Six1 protein levels in cell extracts were determined by western blotting. β-actin was used as a loading control. (B) Cell
morphology of HKc/HPV16-Ctrl and HKc/HPV16-Six1. Images are shown at 100 magniﬁcation. (C) Proliferation of HKc/HPV16-Six1 (HKc-Six1), HKc/HPV16-Ctrl (HKc-Ctrl)
and HKc/HPV16 (HKc). Cell numbers were determined by manually counting cells on the days indicated. (D) Invasion (upper panels) and migration (lower panels) assays for
HKc/HPV16-Ctrl and HKc/HPV16-Six1. Cell invasion was determined by a Matrigel invasion assay, and cell migration was determined by a transwell migration assay. Images
for the invasion assay are shown at 400 and those for the migration assay at 100 magniﬁcation. Quantiﬁcation of the invasion assay and the migration assay are shown
in the upper right and lower right panels, respectively. Each column represents the mean of ﬁve different ﬁelds. Bars indicate SD, and nn and nnn indicate statistically
signiﬁcant p values o0.01 and 0.001 respectively.
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complex and promotes early keratinocyte differentiation (Xie and
Bikle, 2007). However, we did not observe any signiﬁcant increase in
phospho-PI3K or phospho-AKT in response to high calcium treat-
ment (Supplemental Fig. 2). Taken together, our data strongly
indicate that overexpression of Six1 in HKc/HPV16 results in resis-
tance to Ca2þ or serum-induced differentiation. The resistance to
Ca2þ induced differentiation by Six1 is not induced through activa-
tion of the PI3K pathway by E-cadherin-β-catenin.
Smad-dependent TGF-β signaling is decreased in association with
Six1 overexpression
Next, we explored possible mechanisms by which Six1 over-
expression in HKc/HPV16 leads to resistance to calcium/serum-
induced differentiation. Cell cycle exit is one of the major pro-
cesses involved in entering the terminally differentiated state
(Missero et al., 1995, 1996). TGF-β-Smad2/3 signaling induces cell
cycle withdrawal during keratinocyte terminal differentiation
(Descargues et al., 2008), and TGF-β1 enhances differentiation of
HKc under high Ca2þ conditions (Matsumoto et al., 1990). More-
over, TGF-β signaling is important in Six1-induced EMT (Micalizzi
et al., 2009, 2010). Compared to HKc/HPV16-Ctrl, mRNA levels of
TβRII and TβRIII in HKc/HPV16-Six1 were increased 1.7-fold and
4.3-fold, respectively, while TβRI mRNA was slightly decreased
(Fig. 6A). In addition, increases in the protein levels of TβRII and
TβRIII in HKc/HPV16-Six1 were detected by western blotting
(Fig. 6B). We next investigated whether Six1-induced EMT and
differentiation resistance are linked to altered TGF-β-Smad2/3
signaling. We compared both the basal and TGF-β stimulated
activity of a Smad-responsive luciferase reporter cons-
truct (p6SBE-Luc) in HKc/HPV16-Ctrl with HKc/HPV16-Six1.
Six1 overexpression did not change the basal activity of the
Smad-dependent reporter construct (data not shown). However,
activation of Smad-dependent signaling in response to TGF-β1
treatment was attenuated by 45% in HKc/HPV16-Six1 as com-
pared with HKc/HPV16-Ctrl (Fig. 6C). These data suggest that Six1
overexpression decreases activation of Smad-dependent signaling
in response to TGF-β1 treatment despite increasing the levels of
TβRII and TβRIII.
Six1 activates ERK and p38 MAPK signaling
The Mitogen-Activated Protein Kinases (MAPKs) are central
players in regulating keratinocyte differentiation (Eckert et al.,
2002). MAPK signaling is one of the non-Smad TGF-β pathways
(Zhang, 2009) and we have previously found that activation of
MAPK is involved in Six1-induced EMT in HKc/DR (Xu et al., 2014).
We compared MAPK activity in HKc/HPV16-Ctrl and HKc/HPV16-
Six1 by conducting Western blots using phospho-speciﬁc p-ERK,
p-p38 and p-JNK antibodies. As shown in Fig. 7A, phosphorylation
of ERK and p38, but not JNK, was dramatically increased in
response to Six1 overexpression in HKc/HPV16. After treatment
of HKc/HPV16-Ctrl with 1 mM Ca2þ , ERK was phosphorylated
within 1 h, and increased phosphorylation of p38 was detected as
soon as 10 min after Ca2þ treatment. In contrast, in HKc/HPV16-
Six1, the phosphorylation of ERK and p38 was not further
increased but rather decreased within 1 h after high Ca2þ treat-
ment (Fig. 7B). Signal transducer and activator of transcription 3
(STAT3) also plays an important role in differentiation, migration
and apoptosis of keratinocytes (Saeki et al., 2012). The phosphor-
ylation of STAT3 increased in HKc/HPV16-Six1 compared to
HKc/HPV16-Ctrl (Fig. 7B). However, there is no STAT3 activ-
ation in HKc/HPV16-Ctrl following high Ca2þ treatment and the
Fig. 3. Six1 overexpression induces EMT in HKc/HPV16. (A) mRNA expression of E-cadherin, occludin, vimentin and snail were determined by Real-time PCR in HKc/HPV16-
Ctrl (HKc-Ctrl) and HKc/HPV16-Six1 (HKc-Six1) cultured in complete medium. Data were normalized to β-actin expression. Bars indicate SD, and n, nn and nnn indicate
statistically signiﬁcant p values o0.05, 0.01 and 0.001 respectively. (B) Western blot for Six1, E-cadherin, ﬁbronectin and β-catenin in HKc/HPV16-Ctrl (Ctrl) and HKc/HPV16-
Six1 (Six1) cultured in complete medium. β-actin was used as loading control. (C) Immunoﬂuorescent staining of E-cadherin (red) (left panels) and ﬁbronectin (red) (right
panels) in HKc/HPV16-Ctrl and HKc/HPV16-Six1 cultured in complete medium. Nuclei were stained with DAPI (blue). Images are shown at 400 magniﬁcation.
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phosphorylation of STAT3 decreased in HKc/HPV16-Six1 following
the addition of high Ca2þ medium (Fig. 7B).
Discussion
There is evidence that the inappropriate expression of homeo-
box genes contributes to tumorigenesis and tumor progression
(Abate-Shen, 2002). The Six1 homeoprotein is essential for
embryonic development, and also contributes to cancer cell
proliferation and survival. The overexpression of Six1 has been
found in various cancers, and is associated with increased tumor
progression and metastasis, and decreased survival (Christensen
et al., 2008). Our previous work determined that SIX1 mRNA
expression increased during in vitro progression of HPV16-
immortalized HKc toward a differentiation resistant phenotype
(HKc/DR) and that Six1 protein was overexpressed in cervical
cancer tissues, which strongly suggests that Six1 might play an
important role in the progression of premalignant cervical lesions
initiated by HPV infection (Wan et al., 2008). In the current study,
we focused on the role of Six1 at early stages of HPV16-mediated
transformation. Interestingly, we found that Six1 overexpression
in HKc/HPV16 induces resistance to calcium- and serum-induced
differentiation, a hallmark of HKc/DR. Resistance to calcium and
serum-induced differentiation in HKc/HPV16 overexpressing Six1
was associated with ERK and p38 MAPK activation.
MAPKs play a vital role in regulating keratinocyte differentiation
(Eckert et al., 2002). For example: P38 MAPK functions to promote
HKc differentiation by regulating the expression of involucrin, a
marker of keratinocyte differentiation (Dashti et al., 2001). High
calcium induces a transient, peak-like activation of ERK in HKc, and
calcium-induced differentiation can be blocked by MEK inhibition,
which suggests an important role of the MEK/ERK pathway in the
early stages of keratinocyte differentiation (Schmidt et al., 2000).
We show that the level of phosphorylation of ERK and p38
increased in HKc/HPV16-Ctrl upon high calcium treatment. In
contrast, the basal levels of p-ERK and p-p38 are very high in
HKc/HPV16-Six1 and the phosphorylation levels of ERK and p38
actually decreased in HKc/HPV16-Six1 following treatment with
high calcium. STAT3 also has been known to play an important role
in keratinocyte differentiation. Constitutive activation of STAT3 in
mouse epidermis results in partial loss of the keratinocyte differ-
entiation markers K10 and ﬁlaggrin and enhances malignant
progression (Chan et al., 2008). STAT3 knock-down sensitizes
terminal differentiation of HKc at low-calcium condition (Saeki
et al., 2012). Our study showed a signiﬁcant activation of STAT3 in
Six1-overexpressing HKc/HPV16. STAT3 overexpression in HKc/
HPV16-Six1 may in fact delay differentiation even though these
cells express high levels of p-ERK and p-p38.
TGF-β signaling plays a dual role in tumor progression, and
dysregulation of TGF-β signaling is thought to be associated with
progression of premalignant cervical lesions to cervical cancer
(Baritaki et al., 2007; Noordhuis et al., 2011). TGF-β acts as a potent
tumor suppressor since it strongly inhibits the proliferation of
normal and early neoplastic cells. However, at late stages of
tumorigenesis, tumors become resistant to TGF-β mediated growth
Fig. 4. Six1 overexpression in HKc/HPV16 results in resistance to serum and calcium-induced differentiation. (A) HKc/HPV16-Ctrl and HKc/HPV16-Six1 were cultured with
either complete medium or complete medium supplemented with 1 mM calcium chloride or 5% FBS for 5 days. Cell morphology of HKc/HPV16-Ctrl and HKc/HPV16-Six1
under the indicated treatment is shown in the ﬁrst column (Phase). Immunoﬂuorescent staining of nuclei with DAPI (blue), E-cadherin (red) and keratin 10 (green) in HKc/
HPV16-Ctrl (upper panels) and HKc/HPV16-Six1 (lower panels) is shown in columns 2–4. (B) Cell morphology of HKc/HPV16-Ctrl and HKc/HPV16-Six1 cultured in complete
medium (Ctrl) or complete medium containing high calcium (1 mM Ca2þ) or FBS for 24 h. Images are shown at 100 magniﬁcation.
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Fig. 5. Six1 overexpression in HKc/HPV16 does not impact the redistribution of adhesion junctions when cultured in high calcium media. (A) Western blot of keratin 10,
ﬁbronectin and E-cadherin in whole cell lysates from HKc/HPV16-Ctrl and HKc/HPV16-Six1 that were treated with media containing 1 mM Ca2þ for the indicated times.
β-actin was used as a loading control. (B) The expression of E-cadherin in soluble (cytosolic) and insoluble (cytoskeleton-associated) fractions from HKc/HPV16-Ctrl and HKc/
HPV16-Six1 that were treated with 1 mM Ca2þ for the indicated times. Fractions were analyzed by western blotting.
Fig. 6. Six1 overexpression in HKc/HPV16 alters TGF-β signaling. (A) mRNA expression of TGF-β receptors TβRI, TβRII and TβRIII were determined by Real time PCR in HKc/
HPV16-Ctrl (HKc-Ctrl) and HKc/HPV16-Six1 (HKc-Six1). Data were normalized to β-actin expression. (B) Western blot analysis of TβRII and TβRIII in HKc/HPV16-Ctrl (Ctrl) and
HKc/HPV16-Six1(Six1). β-actin was used as a loading control. (C) HKc/HPV16-Ctrl (HKc-Ctrl) or HKc/HPV16-Six1 (HKc-Six1) were transfected with either p6SBE-luc (SBE) or
p6SME-luc (SME). 24 h after transfection, cells were treated with 40 pM TGF-β1 for 24 h and then luciferase activity determined. Values were normalized to Renilla luciferase.
Bars indicate SD, and nn and nnn indicate statistically signiﬁcant p values o0.01 and o0.001 respectively.
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inhibition and exploit TGF-β signaling to facilitate tumor metastasis
and invasion (Meulmeester and Ten Dijke, 2011). Although HKc/
HPV16 are initially as sensitive as normal HKc to the antiprolifera-
tive effects of TGF-β, HKc/HPV16 become increasingly resistant to
the antiproliferative effects of TGF-β during in vitro progression (Mi
et al., 2000). In fact, HKc/DR are completely resistant to the
antiproliferative effects of TGF-β and exhibit decreased expression
of TβRI (Hypes et al., 2009; Mi et al., 2000). However, in HKc/DR the
Smad pathway remains relatively intact, although TGF-β activation
of Smad-dependent signaling is reduced by about 50% (Altomare
et al., 2013; Kowli et al., 2013). Despite a partial loss of Smad-
dependent signaling in HKc/DR, TGF-β treatment of HKc/DR results
in modulation of the expression of genes associated with EMT
(Kowli et al., 2013). In the present study we found that Six1
overexpression in HKc/HPV16 reduced Smad-dependent signaling
in response to TGF-β1 to about the same extent (about 45%) as we
previously reported in HKc/DR (Altomare et al., 2013; Kowli et al.,
2013). It is possible that decreased Smad-dependent signaling may
contribute to the enhanced proliferation we observed in HKc/
HPV16-Six1 compared to HKc/HPV16-Ctrl. We previously reported
that Six1 overexpression in HKc/DR decreased cell proliferation
while promoting EMT and malignant conversion (Xu et al., 2014).
The basis for the different growth responses to Six1 overexpression
in HKc/HPV16 and HKc/DR is likely to involve alterations in TGF-β
signaling, but the molecular mechanisms of this alteration are not
completely understood. For example, the sensitivity of HKc/HPV16-
Six1 to the antiproliferative effects of TGF-β still remains to be
determined. TGF-β is one of the primary serum factors responsible
for inducing keratinocytes to undergo terminal differentiation
(Bertolero et al., 1986). Thus, the decreased Smad signaling found
in HKc/HPV16-Six1 likely plays some role in the resistance of these
cells to serum-induced differentiation.
EMT allows immotile and polarized epithelial cells to acquire a
motile, apolar and ﬁbroblastoid phenotype, and is considered a critical
step in mediating tumor progression, metastasis as well as cancer
stem cell properties (Christiansen and Rajasekaran, 2006; Mani et al.,
2008). TGF-β can induce EMT through both Smad-dependent and
non-Smad signaling (Lamouille et al., 2014; Zhang, 2009). In this
study we found increased expression of TβRII and TβRIII in Six1-
overexpressing HKc/HPV16, but we did not ﬁnd any increase in Smad-
dependent signaling. After examining typical non-Smad TGF-β path-
ways, we showed a signiﬁcant activation of ERK and p38 MAPK in
response to Six1 overexpression in HKc/HPV16. Inhibition of ERK and
p38 MAPK activity in HKc/HPV16-Six1 signiﬁcantly decreases the
expression of ﬁbronectin (a mesenchymal marker) and the cells also
lose their ﬁbroblastic appearance (data not shown). These ﬁndings
are consistent with our observation in HKc/DR, in which Six1 over-
expression activates MAPK, and MAPK activation is critical for Six1-
induced EMT (Xu et al., 2014).
We previously reported the cellular responses to Six1 over-
expression at late stages of HPV16-mediated transformation (HKc/
DR) (Xu et al., 2014) and in this study we report the cellular effects
of Six1 over expression at the early stages of HPV16-mediated
transformation (HKc/HPV16). When comparing cellular responses
to Six1 overexpression in HKc/HPV16 to HKc/DR, many of the
responses are similar, including; increased cell invasion and mig-
ration, induction of EMT, increases in TβRII and TβRIII, and
activation of ERK and p38 MAPK (Xu et al., 2014). Inhibition of
MAPK activation or TβRII-mediated signaling results in the rever-
sal of Six1-induced EMT. These results suggest that Six1 promotes
EMT through TβRII and MAPK signaling. However, HKc/HPV16 and
HKc/DR also show some different responses to Six1 overexpres-
sion. For example, HKc/HPV16-Six1 are resistant to calcium-
induced differentiation, which is a hallmark of HKc/DR, but are
not tumorigenic (data not shown); while HKc/DR-Six1 are tumori-
genic and form tumors in the ﬂank of nude mice, indicating that
other genetic alterations during HPV16-mediated transformation
are also important for malignant conversion (Xu et al., 2014).
Additionally, Six1 overexpression increases proliferation of HKc/
HPV16 in vitro, but decrease proliferation in HKc/DR. Our
previously published studies demonstrated that HKc/DR have
decreased expression of TβRI compared to HKc/HPV16, which
accompanies resistance to the antiproliferative effects of TGF-β
(Mi et al., 2000). The different growth response to Six1 over-
expression in HKc/HPV16 and HKc/DR may be explained by
the different expression of TGF-β receptors and TGF-β signaling.
Finally, in HKc/DR, p38 activation plays a dominant role in Six1-
induced EMT; and in HKc/HPV16, both ERK and p38 contribute to
the EMT associated with Six1 overexpression. This observation
may be explained by the decreased phosphorylation of p38 in
HKc/DR compared to HKc/HPV16 (data not shown), which makes
the activation of p38 in HKc/DR exhibit a more robust response.
In summary, Six1 overexpression in HKc/HPV16 increases cell
proliferation, invasion, migration, and EMT and induces resistance
Fig. 7. Six1 overexpression in HKc/HPV16 activates MAPK signaling. (A) Protein levels of p-ERK, ERK, p-p38, p38, p-JNK and JNK were determined by western blotting of cell
lysates prepared from HKc/HPV16-Ctrl and HKc/HPV16-Six1. (B) Western blot of p-ERK, p-p38, p-JNK and p-STAT3 in HKc/HPV16-Ctrl and HKc/HPV16-Six1 that were
cultured in medium containing 1 mM Ca2þ for the indicated times. β-actin was used as a loading control.
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to calcium and serum-induced differentiation. Although TβRII and
TβRIII levels are increased in HKc/HPV16-Six1, Smad-dependent
TGF-β signaling is reduced, while MAPK is activated. Activation of
MAPK in HKc/HPV16 overexpressing Six1 is associated with
resistance to calcium-induced terminal differentiation, although
the precise mechanism remains to be determined.
Materials and methods
Cell culture and treatment
The HKc/HPV16 and HKc/DR cell lines used in this work have
been described in detail previously (Pirisi et al., 1988, 1987). HKc/
HPV16 were cultured in keratinocyte serum free medium supple-
mented with EGF and BPE (Invitrogen, Carlsbad, CA). This medium
is referred to as complete medium. HKc/HPV16 were transfected,
using TransFast reagent (Promega, Madison, WI), with the mam-
malian expression vector pcDNA3.1 (Invitrogen) alone (HKc/
HPV16-Ctrl) or pcDNA3.1 containing full-length human Six1 cDNA
that was cloned into the NheI and BamHI site (HKc/HPV16-Six1)
(Xu et al., 2014). Stable transfectants of HKc/HPV16-Ctrl and HKc/
HPV16-Six1 (originating from our HKc/HPV16D-4 line) were
selected in complete medium containing 50 mg/ml Zeocin (Invitro-
gen) (Pirisi et al., 1988). All experiments were conducted using the
same clonal HKc/HPV16-Six1 cell line. For differentiation resis-
tance experiments, HKc/HPV16-Ctrl and HKc/HPV16-Six1 were
cultured with either complete medium or complete medium
supplemented with 1 mM calcium chloride or 5% fetal bovine
serum (FBS) for the indicated times. All cells were maintained in a
humidiﬁed atmosphere of 5% CO2 at 37 1C.
Real time PCR
Total RNA was isolated from cells using the Total RNA Isolation
Mini Kit (Agilent, Wilmington, DE). Reverse transcription was carried
out with 1 μg of total RNA using the iScript cDNA Synthesis Kit
(BioRad, Hercules, CA). Real time PCR was performed using iQ SYBR
Green Supermix (BioRad). All the procedures were according to the
manufacturer's instructions. The DNA sequence of the primers used
for real time PCR have previously been reported (Xu et al., 2014).
β-actin was used as an internal control. All samples were analyzed
in triplicate.
Antibodies and western blot analysis
Cells lysates were prepared using RIPA buffer (Pierce, Rockford, IL).
Antibodies against the following proteins were used: Six1, transform-
ing growth factor-beta (TGF-β) type II receptor (TβRII), TGF-β type III
receptor (TβRIII) (all at 1:1000 dilution, Santa Cruz Biotechnology,
Santa Cruz, CA), E-cadherin, ﬁbronectin (at 1:10,000 dilution, BD
Biosciences, San Jose, CA), ERK, p-ERK, JNK, p-JNK, p38, p-p38,
p-STAT3, keratin 10 (all at 1:3000 dilution, Cell Signaling Technology,
Danvers, MA). The blots were incubated with primary antibody
overnight at 4 1C, washed three times with PBST, followed by
incubation with HRP-conjugated secondary antibody (at 1:10,000
dilution, Millipore, Temecula, CA). The blots were visualized using
the ECL Prime Western Blotting Detection System (GE Healthcare,
Buckinghamshire, UK). β-actin was used as an internal control for
equal protein loading. For Triton X-100-soluble and -insoluble protein
fraction experiments, cell extracts were prepared as previously
described (Sadot et al., 1998).
Cell proliferation assay
To compare the growth rate of HKc/HPV16, HKc/HPV16-Ctrl
and HKc/HPV16-Six1, 50,000 cells in 2 ml of their respective media
were plated per well in 6-well plates. Cells plated in triplicate
wells were counted daily for 5 days using a hemocytometer.
Cell invasion and migration assay
The invasive ability of HKc/HPV16-Ctrl and HKc/HPV16-Six1
was determined using transwell chambers (24 well plate) (Costar,
Cambridge, MA) with polycarbonate membranes (8.0-μm pore
size) coated with 100 μl Matrigel (BD Biosciences, Franklin Lakes,
NJ) on the top side of the membrane. Then, 20,000 cells per well in
basal medium containing 0.1% bovine serum albumin were plated
in upper chamber. The lower chamber contained complete med-
ium. After 24 h the cells were ﬁxed with methanol and stained
with 0.1% crystal violet. Cells and Matrigel on the upper surface of
the membrane were carefully removed with a cotton swab. Cells
were quantiﬁed by visually counting cells in ﬁve randomly chosen
areas. The migration of cells was measured by counting cells
migrated to the lower chamber. Each experiment was performed
in triplicate wells and repeated three times.
Immunoﬂuorescence
HKc/HPV16-Ctrl and HKc/HPV16-Six1 were plated in Lab-Tek II
chambers (Nalge Nunc International, Rochester, NY) for 24 h. Follow-
ing treatment, ﬁxation (with 2% paraformaldehyde in PBS, pH 7.2) and
permeabilization (with 0.1% Triton X-100 in PBS), samples were
incubated with antibodies against E-cadherin (at 1:200 dilution),
ﬁbronectin (at 1:200 dilution) and keratin 10 (at 1:100 dilution)
overnight at 4 1C. Samples were then washed three times with PBST,
followed by incubation with FITC- and Alexa 568- conjugated second-
ary antibodies (at 1:1000 dilution, Invitrogen). Nuclei were stained
with a 1:20,000 dilution of 40, 6-diamidino-2-phenylindole (DAPI)
(Invitrogen) before cells were mounted. Samples were observed using
an Olympus X81 ﬂuorescence microscope.
Luciferase assays
Cells were plated into 6-well plates. Transfections were per-
formed using TransFast Transfection Reagent (Promega) according
to the manufacturer's instructions. The luciferase construct p6SBE-
luc, which contains six copies of the Smad binding element (SBE) and
p6SME-luc, which contains Smad mutated elements (SME) were
obtained from Dr. Scott Kern (Dai et al., 1998). For each well, cells
were transfected with either 4 mg p6SBE-luc or 4 mg p6SME-luc,
along with 4 ng pRL-SV40 (Promega) Renilla luciferase as a control
for transfection efﬁciency. Cells were treated with human TGF-β1
(R&D Systems, Minneapolis, MN) or vehicle 24 h after transfection.
Both ﬁreﬂy and Renilla luciferase activity were measured using the
Dual Luciferase Assay Kit (Promega) 24 h after treatment. Fireﬂy
luciferase values were normalized to Renilla luciferase values.
Statistical analysis
Data were expressed as the mean7standard deviation (SD).
Statistical analysis was performed using a student's t-test when
only two value sets were compared, and by one-way ANOVA
followed by Dunnett's test when the data involved three or more
groups. Po0.05, Po0.01 or Po0.001 were considered statistically
signiﬁcant and indicated in the ﬁgures by n, nn or nnn respectively.
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